Evaluation of nephrotoxicity and ototoxicity following amikacin administration once daily or every 48 hours in neonates

Autor: Aiju Endo, Kazumi Hanawa, Atsushi Nemoto, Takahiro Ishikawa, Shizuka Kazama, Yu Kagami, Yuki Maebayashi, Nobuyuki Katsumata, Atsushi Naito, Yoshifumi Kobayashi, Yayoi Kawano, Takehisa Hanawa

Publikováno v: Medicine. 101(43)

The purpose of this study was to evaluate the effects of once daily (OD) or every 48 hours (every-48-h) administration of amikacin (AMK) on renal function and ototoxicity in neonates. We investigated the frequency of nephrotoxicity and ototoxicity in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f2613f3738a52c5a91f722e35b7e53f
https://pubmed.ncbi.nlm.nih.gov/36316882

Relationship between amikacin blood concentration and ototoxicity in low birth weight infants

Autor: Yoshifumi Kobayashi, Kazumi Hanawa, Yohei Hasebe, Mami Kobayashi, Seiichi Yamamoto, Atsushi Nemoto, Aiju Endo, Atsushi Naito, Yuki Maebayashi, Katsuhiko Isobe

Publikováno v: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 25(1)

Amikacin (AMK) is used as empiric therapy for severe infections such as sepsis in low birth weight (LBW) infants. AMK administered once daily (OD) in adults is reported to be therapeutically effective and prevent side effects, however, evidence on AM

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bb5e6d1d7d317acd2c9fd526a5ed7c3
https://pubmed.ncbi.nlm.nih.gov/30539740

Effect of insulin-like growth factor-binding protein 7 on steroidogenesis in granulosa cells derived from equine chorionic gonadotropin-primed immature rat ovaries

Autor: Kazuhiro Tamura, Mayumi Matsushita, Hiroshi Kogo, Aiju Endo, Masahiko Kutsukake

Publikováno v: Biology of reproduction. 77(3)

Insulin-like growth factor (IGF)-binding protein (IGFBP) 7 is a secreted protein that regulates cellular proliferation, adhesion, and angiogenesis, and has low affinity for IGF compared with that of IGFBP1-IGFBP6. We sought to determine whether IGFBP

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4df35023d23970f136852048b1f6d694
https://pubmed.ncbi.nlm.nih.gov/17522074

Building vancomycin population pharmacokinetic model for Japanese low birth weight infants in comparing it with previously reported pediatric population pharmacokinetic models.

Autor: Masuda KOJI; International University of Health and Welfare Narita Hospital, Department of Infection Control and Prevention, 852, Hatakeda, Narita, Chiba 286-8520 Japan. Electronic address: masuda.koji@iuhw.ac.jp., Ikeda KENJI; Osaka University, Clinical Pharmacy Research and Education Unit, Graduate School of Pharmaceutical Sciences, 1-6, Yamadaoka, Suita, Osaka, 565-0871, Japan., Endo AIJU; Yamanashi Prefectural Central Hospital, Department of Pharmacy, 1-1-1 Fujimi, Kofu, Yamanashi, 400-8506, Japan., Ishikawa TAKAHIRO; Yamanashi Prefectural Central Hospital, Department of Pharmacy, 1-1-1 Fujimi, Kofu, Yamanashi, 400-8506, Japan., Matsumoto TETSUYA; International University of Health and Welfare Narita Hospital, Department of Infection Control and Prevention, 852, Hatakeda, Narita, Chiba 286-8520 Japan.

Publikováno v: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2024 Dec 11. Date of Electronic Publication: 2024 Dec 11.